No results for ‘’
Innova Captab Ltd
NSE: INNOVACAP BSE: 544067
₹973.25
(1.10%)
Thu, 23 Jul 2026, 04:38 pm
Market Cap (in Cr)5510.19
PE Ratio39.52
Dividend0.20
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2005
- The Company was incorporated as ?Harun Health Care Private Limited?
2006
- Established the first manufacturing plant in Baddi, Himachal Pradesh
2009
- Passed a resolution to change the name of the Company from ?Harun Health Care Private Limited? to ?Innova Captab Private Limited?
2010
- Changed the name of the Company from ?Harun Health Care Private Limited? to ?Innova Captab Private Limited?
- Commenced operations at the cephalosporin block of the plant in Baddi, Himachal Pradesh
2013
- Crossed ?500.00 million in total revenue
- Received the first international accreditation in the form of certificate of good manufacturing practices for all manufacturing activities of the Company in relation to the cephalosporin products from the Ministry of Medical Services, Republic of Kenya
2015
- Incorporated Univentis Medicare Limited through which the Company undertakes marketing operations
2018
- Converted the Company from a private limited company to a public limited company
- Changed the name of the Company to ?Innova Captab Limited?
2019
- Crossed ?3,000.00 million in total revenue
2021
- Leased land to establish an industrial plant at Samba, Jammu and Kashmir
- Acquired land to build a state of art research and development centre in Panchkula, Haryana
- Acquired the assets and liabilities of Innova Partnership on going concern through slump sale
- Acquired Univentis Medicare Limited as a wholly owned subsidiary
2023
- Acquired Sharon Bio-Medicine Limited through the wholly owned subsidiary Univentis Medicare Limited.